Visual field progression in patients with severe glaucoma
dc.contributor.author | Maul, Eugenio J. | |
dc.contributor.author | Kastner, Alan | |
dc.contributor.author | Schmidt, Jimena | |
dc.contributor.author | Tapia, Jaime A. | |
dc.contributor.author | Morales, Cristobal | |
dc.contributor.author | Maul, Eugenio A. | |
dc.date.accessioned | 2025-01-20T23:55:19Z | |
dc.date.available | 2025-01-20T23:55:19Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Purpose To assess the cumulative risk of progression in glaucomatous eyes in the severe stage of disease. Methods This was a retrospective observational study. Patients that had severe damage in at least one eye, as defined by three criteria including a mean deviation of <= - 20 dB, were included. Glaucoma progression was defined as a loss of >= 2 dB in mean deviation confirmed in three consecutive visual field tests, or a persistent loss of two or more lines of vision-not attributable to non-glaucomatous causes-in three consecutive follow-up examinations. Kaplan-Meier survival analysis was used to assess the cumulative incidence of progression of the first eye to reach endpoint in cases where both eyes were eligible. Results A total of 143 eyes from 119 patients, were studied over a mean period of 4.9 +/- 2.9 years. Baseline mean deviation was - 25.3 +/- 3.6 dB. Twenty-three eyes of 22 patients reached the progression endpoint: 14 eyes by visual field criteria and 9 by visual acuity criteria. The cumulative 5-year risk of progression estimated by Kaplan-Meier analysis was 14.6% (95% confidence interval: 6.1-22.2%). Conclusions In severe glaucoma patients, we found a cumulative incidence of progression of 2.9% per year during the first 5 years of follow-up. Similar incidences have been reported in other studies of glaucoma at different stages of severity. | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1007/s00417-020-05036-5 | |
dc.identifier.eissn | 1435-702X | |
dc.identifier.issn | 0721-832X | |
dc.identifier.uri | https://doi.org/10.1007/s00417-020-05036-5 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/95080 | |
dc.identifier.wosid | WOS:000606211000005 | |
dc.issue.numero | 6 | |
dc.language.iso | en | |
dc.pagina.final | 1586 | |
dc.pagina.inicio | 1579 | |
dc.revista | Graefes archive for clinical and experimental ophthalmology | |
dc.rights | acceso restringido | |
dc.subject | Glaucoma | |
dc.subject | Humphrey | |
dc.subject | Visual field damage | |
dc.subject | Progression | |
dc.subject | Severe | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Visual field progression in patients with severe glaucoma | |
dc.type | artículo | |
dc.volumen | 259 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |